Key result
The nonhelical tail, C-terminal phosphorylation sites, and motor domain of the NM2A heavy chain synergistically accelerate the turnover of NM2B in trans and cell motility.
Why the study?
The mechanisms governing nonmuscle myosin 2 filament turnover are not fully understood, particularly how paralog copolymerization enables intrinsically fast NM2A to dynamize intrinsically slow NM2B.
The study reveals that the motor domain, nonhelical tail, and C-terminal phosphorylation sites of NM2A cooperate to regulate NM2 filament turnover and cell motility.
Answers are grounded in this paper and cite their sources.
NM2A domains synergistically accelerate NM2B turnover; leaves open relevance to cardiovascular cell contractility.
Myosin 2, an actin-dependent motor, is universally responsible for cell contractility due to its ability to form bipolar filaments. Fast turnover of nonmuscle myosin 2 (NM2) filaments is necessary to keep up with cell motility and shape changes. The turnover mechanisms are not fully understood and differ for two main mammalian paralogs-NM2A and NM2B-whereas paralog copolymerization adds complexity to this process by enabling the intrinsically fast NM2A to dynamize the intrinsically slow NM2B. Here, we show that the nonhelical tail, the C-terminal phosphorylation sites, and surprisingly, the motor domain of the NM2A heavy chain synergistically accelerate the turnover of NM2B in trans and cell motility, suggesting that these three mechanisms collectively control NM2A's own dynamics. Conversely, the phosphomimetic NM2B tail facilitates only local turnover of endogenous wild type NM2B but not its global redistribution unless the NM2A motor is combined with the phosphomimetic NM2B tail. Collectively, we reveal the cooperation between the motor activity and the NM2 tail-targeting turnover mechanisms in regulating the NM2 filament turnover in trans and cell motility. SUMMARY: Turnover of nonmuscle myosin 2 (NM2) filaments is essential for cell motility and is regulated by various mechanisms including copolymerization of the NM2A and NM2B paralogs. Chougule and Svitkina reveal how the intrinsically fast NM2A accelerates dynamics of slower NM2B in trans.
No takes yet. Share an insight, caveat, or question.
Chougule et al. (2025) studied this question. NM2A and NM2B mutants vs. Wild type or GFP control was evaluated on NM2B filament turnover (halftime of recovery). The nonhelical tail, C-terminal phosphorylation sites, and motor domain of the NM2A heavy chain synergistically accelerate the turnover of NM2B in trans and cell motility.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: